Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : The Trump Presidency -- Ignore unavailable to you. Want to Upgrade?

To: Thomas M. who wrote (225322)	2/7/2022 11:22:17 PM
From: Sam	Read Replies (1) \| Respond to of 361427

Ivermectin suppresses IL-6 and TNFa production, two major components of the cytokine storm: The cytokine storm doesn't happen in the early stages of COVID. But according to your friend, node, that is the only time when ivt is useful. Furthermore, here is the major finding of this study (which, BTW, was done on hamsters, not humans) as far as I can see: Ivermectin might then be considered as promising therapeutic agent against COVID-19 with no impact on SARS-CoV-2 replication but alleviating inflammation and ensuing symptoms. IOW, they are saying it works against cytokine storms by reducing inflammation. It has no effect on COVID itself. Furthermore, they actually say it "might then be considered as promising therapeutic agent" [my bolding]. Not the bolded words--MIGHT and PROMISING. Contrary to your implication and node's repeated claims, it doesn't purport to actually prove anything. It is, like the previous studies that I looked at, something that merely points to ways in which it might be further studied. Here is the most relevant brief summary of the study, which perhaps you and node might actually read and understand: This study shows that the modulation of the host's inflammatory response using ivermectin as a repurposed drug, independently of the viral load, strongly diminished the clinical score and severity of the disease (including anosmia) observed in SARS-CoV-2-infected golden hamsters. This study brings the proof-of-concept that a chemical therapy using ivermectin can preserve the clinical condition by modulating the inflammatory response, even without antiviral activity. The clinical presentation is directly linked to inflammation and not necessarily to viral load. embopress.org I don't think you actually read these things that you post, do you? I am not going to read any more of them. It is kind of useless. But by all means, if you or node actually have real studies that make real claims that are not contradicted by real scientists, I am all ears.